In vitro inhibition of the measles virus by novel ringexpanded('fat') nucleoside analogues containing the imidazo[4,5-e]diazepine ring system
Document Type
Article
Journal/Book Title/Conference
In vitro inhibition of the measles virus by novel ringexpanded('fat') nucleoside analogues containing the imidazo[4,5-e]diazepine ring system
Volume
2
Publication Date
2002
First Page
3391
Last Page
3394
Abstract
The synthesis and in vitro anti-measles virus (anti-MV) activity of a class of ring-expanded (‘fat’) nucleoside analogues (1–4) containing the title heterocyclic ring system are reported. The target compounds were synthesized by base-catalyzed condensations of 4,5-dicarboxylic acidesters of the appropriately substituted imidazole-1-ribosides with suitably substituted guanidine derivatives. Compounds were screened for anti-MV activity in African green monkey kidney cells (CV-1), employing ribavirin as the control standard. While the parent compound 1 itself failed to show any significant antiviral activityagainst MV, its analogues containing hydrophobic substituents at the 2-position (2) or the 6-position (4) showed promising antiviral activityat submicromolar or micromolar concentration levels with no apparent toxicity to the host cell line. Both compounds showed higher anti-MV activity than the control drug ribavirin.
The synthesis and in vitro anti-measles virus activity of ring-expanded nucleosides 1–4 are reported.
Recommended Citation
Zhang, N., Chen, H.M., Sood, R., Kalicharran, K., Fattom, A.I., Naso, R.B., Barnard, D.L., Sidwell, R.W., and Hosmane, R.S. 2002. In vitro inhibition of the measles virus by novel ringexpanded ('fat') nucleoside analogues containing the imidazo[4,5-e]diazepine ring system. Bioorg. Med. Chem. Lett. 2: 3391-3394. PMID: 12419368
Comments
Bioorg. Med. Chem. Lett. 2: 3391-3394. PMID: 12419368